Not recruitingISRCTN22581937
The HELPER programme (Healthy Living and Prevention of Early Relapse): Phase 2: INTERACT
This study isn't currently recruiting.
In United KingdomSchizophreniaResearch study
Schizophrenia studies
Schizophrenia
Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
Not recruitingISRCTN88391730
The impact of routine utilization of two assessment scales on management of antipsychotic-induced side effects
This study isn't currently recruiting.
In United KingdomSchizophreniaResearch study
Not recruitingISRCTN83240263
The MILESTONE study: improving transition from child to adult mental health care
This study isn't currently recruiting.
In United KingdomSchizophreniaResearch study
CompletedNCT06556966
A Study Assessing the Safety and Tolerability of LY03020 in Chinese Healthy Subjects
Official study title
A Phase Ⅰ, Randomized, Double-blind, Placebo-controlled, Single Dose Ascending Study to Assess the Safety, Tolerability, and Pharmacokinetics of LPM787000048 Maleate Sustained-release Tablet (LY03020) in Chinese Healthy Adult Subjects
This study has finished and is no longer accepting participants.
In BeijingSchizophreniaMedication studyAges 18–45
CompletedNCT00249119
Effectiveness of effectiveness and Safety of Risperidone Compared With Haloperidol in schizophrenia
Official study title
Risperidone in the Treatment of Chronic Schizophrenic Patients: an International Multicentre Double-blind Parallel-group Comparative Study Versus Haloperidol.
This study has finished and is no longer accepting participants.
Location not clearly listedSchizophreniaMedication studyAges 18–65
CompletedNCT04898270
Adjunctive Use of Fute (Flupentixol) in Multi-acting Receptor-targeted Antipsychotics Treated Schizophrenia Patients
What is this study about?
This study evaluated the effectiveness of Flupentixol for people with schizophrenia.
This study has finished and is no longer accepting participants.
In TaichungSchizophreniaMedication studyAges 20–65
TerminatedNCT01139125
An Open study of Cysteamine Treatment in Schizophrenia
Official study title
An Open Trial of Cysteamine Treatment in Schizophrenia
This study ended early.
In AugustaSchizophreniaMedication studyAges 18–60
CompletedNCT00401973
Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain Associated With Olanzapine
Official study title
The Assessment of the Safety, Efficacy, and Practicality of an Algorithm Including Amantadine, Metformin and Zonisamide for the Prevention of Olanzapine-Associated Weight Gain in Outpatients With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including National CitySchizophreniaMedication studyAges 18–65
CompletedNCT00645502
Bioequivalence Study Comparing 2 Formulations for 4 mg Risperidone Tablet.
Official study title
A Bioequivalence Study Comparing a Single Oral Intake of a 4mg Orally-disintegrating Tablet With a 4mg Conventional Risperdal Tablet in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
Location not clearly listedSchizophreniaMedication studyAges 18–65
CompletedNCT02653729
Cbt for Psychosis and Affect on Psychosis Symptoms
Official study title
Cognitive Behaviour Therapy for Psychosis in First Episode Patient and the Outcome of Cognitive Behaviour Therapy on Psychotic Symptoms
This study has finished and is no longer accepting participants.
Location not clearly listedSchizophreniaMedication studyAges 18–35
CompletedNCT04325386
Clozapine CHAMPION-ECHO Educational Study to Improve Clozapine Use.
Official study title
Clozapine CHAMPION-ECHO (Center for Help and Assistance for Maryland Prescribers- Improving Outcomes Network Using Extension for Community Healthcare Outcomes); Randomized Educational Study to Improve Clozapine Prescribing Through a Project ECHO Model
This study has finished and is no longer accepting participants.
In CatonsvilleSchizophreniaPlacebo comparisonAges 22–85
CompletedNCT01279213
Clozapine/Paliperidone Versus Clozapine/Placebo in Resistant Schizophrenia
Official study title
Augmentation of Clozapine With Paliperidone in the Treatment of Resistant Schizophrenia Randomized Controlled Study
This study has finished and is no longer accepting participants.
In RosarioSchizophreniaMedication studyAges 20–50
Registry coverage
We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.